World leading laboratory launches clinical trials testing
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Appendix 4C - March 2017 Quarterly Report
- PromarkerD Update
- Frost & Sullivan- PromarkerD diagnostic test world leading
- Proteomics targets diabetic kidney disease in Asia
- Diabetic Kidney Disease Diagnostic Test Data Published
Later from Proteomics International Laboratories
- Clinical validation study confirms PromarkerD performance
- Response to ASX Query
- Proteomics wins major analytical services contract
- Appendix 4C - June 2017 Quarterly Report
- Appendix 4C - corrected
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories